Go offline with the Player FM app!
#129: Hope for Myelin Repair: How Stem Cells Could Change the Future of Progressive MS with Dr. Luca Peruzzotti Jametti
Manage episode 504164506 series 3562061
Neural stem cells may calm brain inflammation and enable myelin repair in progressive MS. Safety looks promising; phase-2 planning is underway.
You can read the interview extract on my blog: https://ms-perspektive.com/129-luca-peruzzotti-jametti
Progressive MS needs therapies that work inside the brain. In this episode, Dr. Luca Peruzzotti Jametti explains why remyelination is so hard in humans, how neural stem cells (NSCs) can calm chronic inflammation through paracrine signals, and when true myelin repair may be feasible. We discuss Phase-1 safety data, the road to Phase-2, who might benefit first (likely progressive MS), and how metabolic approaches to mitochondria/bioenergetics could stack with cell therapies. Dr. Jametti also shares a realistic timeline (5–10 years for larger trials) and a hopeful outlook on disability reversal within 10–15 years. Resources and lab/social links below.
We cover:
Relapses vs. PIRA and microglia
Why human remyelination often stalls
NSCs: paracrine effects vs. cell replacement
Safety and delivery routes (intraventricular/intrathecal)
Who/when to treat; aHSCT sequencing
Mitochondrial metabolism strategies and the bigger pipeline
Follow the team via the Progressive MS (Cambridge) Facebook page, BlueSky, and Cambridge lab pages. You can also follow our work through the Progressive MS Alliance and the RESTORE consortium.
Dr. Luca Peruzzotti Jametti on PubMed
References & Related Episodes/TopicsPhase-1 NSC transplantation in progressive MS (Cell Stem Cell, 2023) – discussed in interview.
Upcoming therapies mentioned: BTK inhibitors.
See you soon and try to make the best out of your life, Nele
For more information and positive thoughts, subscribe to my newsletter for free.
Click here for an overview of all podcast episodes published so far.
123 episodes
Manage episode 504164506 series 3562061
Neural stem cells may calm brain inflammation and enable myelin repair in progressive MS. Safety looks promising; phase-2 planning is underway.
You can read the interview extract on my blog: https://ms-perspektive.com/129-luca-peruzzotti-jametti
Progressive MS needs therapies that work inside the brain. In this episode, Dr. Luca Peruzzotti Jametti explains why remyelination is so hard in humans, how neural stem cells (NSCs) can calm chronic inflammation through paracrine signals, and when true myelin repair may be feasible. We discuss Phase-1 safety data, the road to Phase-2, who might benefit first (likely progressive MS), and how metabolic approaches to mitochondria/bioenergetics could stack with cell therapies. Dr. Jametti also shares a realistic timeline (5–10 years for larger trials) and a hopeful outlook on disability reversal within 10–15 years. Resources and lab/social links below.
We cover:
Relapses vs. PIRA and microglia
Why human remyelination often stalls
NSCs: paracrine effects vs. cell replacement
Safety and delivery routes (intraventricular/intrathecal)
Who/when to treat; aHSCT sequencing
Mitochondrial metabolism strategies and the bigger pipeline
Follow the team via the Progressive MS (Cambridge) Facebook page, BlueSky, and Cambridge lab pages. You can also follow our work through the Progressive MS Alliance and the RESTORE consortium.
Dr. Luca Peruzzotti Jametti on PubMed
References & Related Episodes/TopicsPhase-1 NSC transplantation in progressive MS (Cell Stem Cell, 2023) – discussed in interview.
Upcoming therapies mentioned: BTK inhibitors.
See you soon and try to make the best out of your life, Nele
For more information and positive thoughts, subscribe to my newsletter for free.
Click here for an overview of all podcast episodes published so far.
123 episodes
All episodes
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.